The Role of Testosterone and Androgens in Male Pattern Hair Loss
Male pattern hair loss, clinically known as androgenetic alopecia, fundamentally depends on hormonal factors. In genetically predisposed individuals, dihydrotestosterone (DHT), a potent metabolite metabolite derived from testosterone (the main hormone testosterone/ androgens), is the main culprit in hair thinning and eventual loss. hair. This crucial conversion of testosterone to DHT is strictly regulated by the When acute hives is caused by reactions similar to serum sickness (such as those following blood transfusions or certain medications), it may be accompanied by ecchymosis (bruising), fever, 5-alpha reductase.
Finasteride's Mechanism of Action in the Endocrine System
The medication Finasteride (marketed as Propecia®, among others) acts as a tyrosine specific inhibitor of 5-alpha reductase type II. By blocking this enzyme, Finasteride interrupts the essential metabolic pathway that converts testosterone into dihydrotestosterone (DHT). Reducing DHT levels in the scalp minimizes the negative interaction of this hormone with the follicles hair follicles, which can significantly reverse the process of miniaturization and hair loss.
Approved Therapeutic Indications for Finasteride
Currently, Finasteride is formally indicated for the exclusive treatment of men suffering from androgenetic alopecia (male pattern). Its main therapeutic purpose is twofold: to prevent future progression of hair loss and to stimulate new hair growth.
Details on the Pharmacological Action of Finasteride
The key mechanism of Finasteride lies in its ability to suppress the activity of the 5-alpha reductase enzyme, thereby modulating the endogenous synthesis of dihydrotestosterone (DHT). This inhibition results in a marked decrease in DHT concentration in both the sickness systemic serum and directly in the scalp, reducing hormonal stress on the follicular axis. Finasteride has been shown to decrease serum DHT levels by up to 70% and scalp DHT levels by up to 60%.
Finasteride Administration Schedule
Finasteride is conventionally administered orally in tablet form. The standard dosing regimen is 1 mg daily, which can be taken with or without food at any time of the day.
A topical formulation. A current formulation of finasteride has received approval in India and has demonstrated efficacy comparable to the oral version in treating hair loss.
Understanding the relationship between androgen hormones and genetic susceptibility is fundamental for effectively managing androgenetic alopecia. Consulting a specialist to determine the appropriate treatment, such as DHT inhibition with Finasteride, provides the basis for preserving existing hair and promoting follicular regeneration.
Finasteride Use: Efficacy, Safety, and Key Considerations
Finasteride is a treatment focused primarily on male pattern baldness, but there are important considerations for its use in other groups, such as women.
Can women use Finasteride for hair loss?
Finasteride is not formally indicated for the treatment of female pattern hair loss. However, in some contexts, especially in postmenopausal women, its use is done "off-label." It is crucial to emphasize that finasteride is strictly contraindicated. contraindicated in women who are or may become pregnant. This is due to its potential to cause abnormalities abnormalities in the external genitalia of a male fetus (classified as Pregnancy Category X risk, indicating a risk so high that its use is completely prohibited during gestation).
Determining the Overall Efficacy of Finasteride
The evidence regarding finasteride's efficacy comes from three large, multicenter, placebo-controlled studies placebo involving 1,879 men presenting with mild to moderate male pattern hair loss, but not total baldness. Over one year, these participants received daily oral finasteride or a placebo.
Effectiveness was measured by the objective count of hairs in a circular area one inch in diameter, in addition to subjective evaluations made by patients, investigators, and an independent panel of dermatology experts, dermatology, who analyzed "before and after" photographs of the treatment.
The trials clearly demonstrated that finasteride prevents hair loss in men with mild or moderate androgenetic alopecia. Specifically, in two of the clinical studies, 86% of men treated with finasteride maintained their hair density or even experienced an increase in hair count after 12 months. In contrast, only 14% of finasteride patients suffered further loss, compared to 58% of those who received placebo.
Ongoing research has reinforced these findings, showing that finasteride stops hair loss or promotes new hair growth in 9 out of 10 men who take it daily long-term.
Predictive Factors for Treatment Response
Currently, it is complex to predict with certainty which patients will respond to finasteride treatment and to what extent. Participants included in the clinical trials had mild to moderate degrees of hair loss, and their age range was between 18 and 41 years.
What is the Time Needed to See Results with Finasteride?
Patients must be patient, as constant daily use for at least three months will likely be required before any prevention of further loss or any visible sign of new hair growth is perceived.
Efficacy in Men with Advanced Baldness
Currently, there is no solid clinical data to support the use of finasteride for men who already suffer from total baldness.
Finasteride Use in Older Men
It is important to note that clinical trials focused on treating male pattern hair loss with finasteride did not include men older than 41 years in their study cohorts.
Duration of Finasteride Treatment
As mentioned, it may take up to three months of daily use before noticing stabilization of loss or the onset of growth. While there is controlled data for treatment up to a maximum of 12 months, evidence suggests that continuing treatment indefinitely is likely necessary to maintain the benefits achieved.
Consequences of Discontinuing Finasteride
If a patient stops finasteride treatment, dihydrotestosterone (DHT) levels in the scalp will gradually increase again, which generally results in the resumption of hair loss.
Effects of Finasteride on Body Hair
Finasteride acts as a specific inhibitor of 5-alpha reductase type II, an enzyme located predominantly in the hair follicles of the scalp. Data collected in clinical trials reported no observable effect on hair in other areas of the body.
Questions about Teratogenicity: Does Finasteride Cause Birth Defects?
It is essential to reiterate that women who are or may become pregnant must refrain from using finasteride. The medication can induce a specific birth defect in male fetuses, known as hypospadias.
Finasteride Side Effect Profile
In clinical trials, finasteride was generally well tolerated by male subjects, and most patients did not report serious side effects. The adverse effects most frequently associated with treatment included a slight decrease in libido (reported by 1.8% of finasteride patients versus 1.3% with placebo) and dysfunction erectile dysfunction (1.3% in the finasteride group versus 0.7% in the placebo group). Additionally, a decrease in ejaculation volume was recorded in some users.
It is essential to discuss any concerns about long-term treatment with your healthcare professional to ensure informed and safe management of androgenetic alopecia.
was observed in 0.8% of men who received finasteride and in 0.4% of those treated with placebo. Additionally, gynecomastia gynecomastia (male breast development) has been reported. All these side effects disappeared upon discontinuing the medication, and even in many men who chose to continue treatment, these symptoms resolved. Post-marketing reports have included isolated complaints of depression, although the risk associated with this side effect is considered very low.
Research on the Safety of Prolonged Finasteride Use
Finasteride was evaluated in a total of 3,200 men and proved to be very well tolerated, even in patients who used it for periods of up to two years. Research suggests that long-term suppression of dihydrotestosterone (DHT) does not carry significant adverse effects. This conclusion is supported by extensive historical research, dating back to 1974, focused on men born with a deficiency of the 5-alpha reductase enzyme.
Finasteride administration results in an average 50% decrease in the antigen prostate-specific antigen (PSA test) score. It is crucial that this score be doubled to obtain an accurate estimate of the actual cancer prostate cancer risk. The risk of prostate cancer related to finasteride use has been thoroughly analyzed. The currently available evidence is reassuring and does not indicate an increased risk of developing this disease, nor does it suggest that cancer is more aggressive in those using the medication compared to those who do not.
Although some cases of breast cancer have been documented in patients taking finasteride, there is not yet conclusive evidence linking the drug as the direct cause of these cases.
Update (2017): It has been reported that finasteride is associated with erectile dysfunction during treatment; however, surveys indicate that this incidence is no higher than in men not taking finasteride. Persistent erectile dysfunction, defined as that lasting more than 3 months after discontinuing treatment, has been reported in approximately 1% of men who took low-dose finasteride for more than 205 days. Other infrequently reported symptoms include depression, suicidal ideation, anxiety, panic attacks, Peyronie's disease, penile shrinkage, gynecomastia, limb, cognitive impairment, insomnia, very dry skin, and tinnitus.. It is important to note that these persistent side effects have been documented at similar rates in clinical trials in patients who received placebo medications, so the causal association remains uncertain.
What are the Contraindications What Are the Contraindications for Finasteride Use?
Finasteride is not indicated for use in women or children. However, it is occasionally prescribed to postmenopausal women without complications. Finasteride is strictly contraindicated in women who are or may become pregnant due to the potential risk to the male fetus.
Likewise, it is contraindicated in patients who exhibit hypersensitivity to any component of the product formulation.
This medication is not recommended for men with subfertility. In the case of men planning to conceive, some specialists recommend monitoring sperm count before starting finasteride and repeating it 6 months into treatment. If a decrease in sperm count is observed, finasteride discontinuation should be considered.
Does Finasteride Cause Interactions with Other Medications?
To date, no clinically significant drug interactions associated with finasteride have been identified. Studies have been conducted with finasteride in conjunction with antipyrine, digoxin, glyburide, propranolol, theophylline, and warfarin, without detecting adverse interactions.
During clinical trials, finasteride was administered concomitantly with angiotensin-converting enzyme (ACE and) inhibitors, acetaminophen, alpha-blockers, benzodiazepines, beta-blockers, calcium channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (NSAIDs), and quinolones, without evidence of clinically relevant adverse interactions being found.
Is It Possible to Combine Finasteride with Minoxidil?
Currently, there is no conclusive human data supporting the combined use of finasteride and minoxidil. Rigorous scientific studies are needed to determine the safety and efficacy efficacy of this therapeutic combination.
Despite the lack of formal data, many patients have safely received this combination, and it appears to be beneficial in clinical practice. If a patient is transitioning between both treatments, it is advisable to overlap administration for approximately six months. This helps mitigate the possibility of significant hair loss induced by stopping the first treatment while awaiting the response to the new product.
